Technical Assistance provided by EQUIP to Ministries of Health closes the gaps that hold back access and uptake of HIV treatment and care services. In an effort to strengthen health systems at national and regional level, EQUIP With the support of USAID, EQUIP currently provides innovative technical assistance to Ministries of Health and local implementation partners [...]
HIV self-testing has the potential to significantly increase HIV testing uptake among at-risk populations, particularly those who are reluctant to get tested at health facilities. Fear of stigma and lack of confidentiality can pose barriers to HIV testing, but this may change with this new HIV testing option. HIV self-testing (HIV ST) has been associated [...]
In October 2015, the World Health Organization issued guidance on what it calls the treat-all approach - or Test & Start - recommending antiretroviral therapy (ART), for everyone living with HIV at any CD4 cell count. Commonly known as Test and Start, this approach begins patients on ART immediately after an HIV-positive diagnosis in an effort to [...]
What is PrEP? PrEP stands for Pre-Exposure Prophylaxis, and it is an additional HIV prevention option. PrEP is for HIV-negative people who are at a high risk of getting HIV. PrEP is a tablet that should be taken daily for as long as a person is at a significant risk of HIV. If you want [...]
EQUIP local implementing partner in Ukraine, Alliance for Public Health, is implementing Direct-Acting Antivirals (DAA)-based Hepatitis C treatment for more than 1,500 HIV/HCV co-infected and HCV mono-infected key populations across the country. Alliance for Public Health is piloting a community supported treatment model, which is significant in reaching key populations and engaging them in HCV care. [...]
EQUIP is proud to introduce our Hepatitis C Demonstration Project partner, the Public Health Center of Ukraine . As a state institution under the Ministry of Health of Ukraine, their priorities are to: promote public health as one of the most significant values of the country and its nation; preserve health and productive life of the [...]
The incubation period for hepatitis C is two weeks to six months. Following initial infection, approximately 80% of people do not exhibit any symptoms. Those who are acutely symptomatic may exhibit: fever fatigue decreased appetite nausea vomiting abdominal pain dark urine grey-coloured faeces, joint pain jaundice (yellowing of skin and the whites of the eyes). [...]
Access to treatment will be now be made easier for people living with HIV/Aids as they will soon be able to collect their medicine at shopping malls thanks to the introduction of special ATM machines. The machines, or rather pharmacy dispensing units, are equipped to dispense medication and are set to be rolled out at [...]
Viral load scale-up involves increasing the viral load testing capacity of labs in a specific country across health facilities. Improving viral load testing and scale-up supports the third of the UNAIDS 90-90-90 targets by enabling viral suppression through effective viral load monitoring. By applying their expertise in the management of large-scale HIV and TB programs [...]
As a Specialist Medical Consultant – Infectious Diseases at Anova Health Institute, an EQUIP Consortium Partner, Dr. Kevin Rebe discusses PrEP (Pre-Exposure Prophylaxis), an evidence-based HIV prevention strategy positioned to complement existing HIV prevention strategies at high risk for acquiring HIV, particularly for Key and Priority Populations. https://youtu.be/SCQGOhZadFI